Nanda Ravenska
Program Studi Sarjana Terapan Administrasi Bisnis Sektor Publik Politeknik STIA LAN Bandung

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

Strategy to Strengthen the Competitiveness of PT Bio Farma's (Persero) Vaccine Business Using Porter's Generic Strategies Approach Desti Mutiah; Caesar Octoviandy Purba; Hafid Aditya Pradesa; Nanda Ravenska
Escalate : Economics and Business Journal Vol. 4 No. 4 (2026): Escalate : Economics and Business Journal
Publisher : Takaza Innovatix Labs Ltd.

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61536/escalate.v4i4.850

Abstract

This research is motivated by the increasingly fierce competition in the vaccine industry and the need for PT Bio Farma (Persero) to maintain and strengthen the competitiveness of its vaccine business. The study aims to analyze the internal and external environments and formulate strategies to strengthen the competitiveness of PT Bio Farma (Persero)'s vaccine business. The study used a qualitative method with a descriptive approach. The research instruments included researchers, interview and observation guides, and documentation. While data analysis was carried out through data collection, reduction, presentation, and verification, followed by IFE, EFE, IE, SWOT, and Porter's Generic Strategies analysis. The results showed that the IE matrix placed the company in quadrant V or hold and maintain with market penetration and product development strategies, while the SWOT matrix generated 12 alternative strategies. The conclusion of the study showed that the differentiation strategy had the highest level of suitability and was the main strategy because it was supported by quality, international standards, R&D, innovation, technology, reputation, service, and distribution.